Day 2: FDA Committee meets to discuss the future of Covid vaccines for ages 6 months to 5 years old

On day 2, June 15,2022, Food and Drug Administration for an upcoming meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss the Moderna EUA request for a COVID-19 vaccine for 6 months through 5 years of age and Pfizer-BioNTech EUA request for 6 months through 4 years of age.The advisory committee under Topic II, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age.

Day 1 meeting:
https://rumble.com/v18rjgs-fda-committee-meets-to-discuss-the-future-of-covid-vaccines-for-ages-6-mont.html

Event Documents:
https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-june-14-15-2022-meeting-announcement#event-materials

*Vaccines and Related Biological Products Advisory Committee June 14, 2022 Meeting Draft Roster
https://www.fda.gov/media/159155/download

Join Banned Deplorables on Telegram
https://t.me/Banned_Deplorables